Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2024-04-15 00:00:00 ET · period of report 2024-04-15 · accession 0001415889-24-010817 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-04-15 | 2024-04-15 | FENC | RALLIS CHRIS A | Dir | S - Sale+OE | $10.45 | -800 | 44.4K | -2% | -$8,360 |
| D | 2024-04-15 | 2024-04-15 | FENC | RALLIS CHRIS A | Dir | M - OptEx | $10.45 | +1,389 | 45.8K | +3% | +$14.5K |
| D | 2024-04-15 | 2024-04-15 | FENC | RALLIS CHRIS A | Dir | M - OptEx | $3.60 | -1,389 | 181.6K | -0.8% | -$5,000 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2024-04-15 | S | D | 800 | $10.45 | 44,449 | D | — | — | (F1) Shares sold to satisfy tax obligation on option exercise. |
| 2 | Common | Common Shares | 2024-04-15 | M | A | 1,389 | $10.45 | 45,838 | D | — | — | (F2) Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on August 17, 2023. |
| 3 | Derivative | Common Shares | 2024-04-15 | M | D | 1,389 | $3.60 | 181,594 | D | $3.60 · 2014-05-15 to 2024-05-15 | 1,389 Options | (F3) Represents options exercised pursuant to a 10b5-1 program adopted August 17, 2023. |